Avatrombopag Impurity 34 - Request Quote
Avatrombopag Impurity 34
| SZ CAT No: | SZ-A084054 |
| CAS No | NA |
| Mol.F. | C27H32Cl2N6O3S2 |
| Mol.Wt. | 623.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Avatrombopag Impurity 34 is chemically 1-(3-Chloro-5-((4-(4-chlorothiophen-2-yl)-5-((2-(cyclohexylamino)ethyl)amino)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid. Avatrombopag Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Avatrombopag Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avatrombopag.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Avatrombopag Impurity 34
Purchase Avatrombopag Impurity 34
Avatrombopag Impurity 34 suppliers
Avatrombopag Impurity 34 manufacturers
Avatrombopag Impurity 34 price
Order Avatrombopag Impurity 34
Enquire Avatrombopag Impurity 34
Avatrombopag Impurity 34 cost
Avatrombopag Impurity 34 Supplier
Avatrombopag Impurity 34 Distributor
Avatrombopag Impurity 34 for Method Validation
Avatrombopag Reference Standard
Avatrombopag Impurity 34 for ANDA Filing
Avatrombopag Impurity 34 for Forced Degradation Studies
Avatrombopag Impurity 34 Identification Standards
Avatrombopag Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.